Guerbet SA (EPA:GBT)
France · Delayed Price · Currency is EUR 13.30
-0.10 (-0.75%)
At close: Feb 20, 2026
Guerbet Market Cap
Guerbet has a market cap or net worth of €167.6 million as of February 20, 2026. Its market cap has decreased by -47.88% in one year.
Market Cap
167.60M
Enterprise Value
514.57M
Revenue
820.92M
Ranking
n/a
PE Ratio
21.66
Stock Price
€13.30
Market Cap Chart
Since March 3, 1992, Guerbet's market cap has increased from 142.85M to 167.60M, an increase of 17.33%. That is a compound annual growth rate of 0.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 167.60M | -6.99% |
| Dec 31, 2025 | 180.20M | -46.68% |
| Dec 31, 2024 | 337.92M | 37.29% |
| Dec 29, 2023 | 246.14M | 14.95% |
| Dec 30, 2022 | 214.13M | -54.42% |
| Dec 31, 2021 | 469.83M | 13.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eurobio Scientific Société anonyme | 236.10M |
| Median Technologies | 177.21M |
| Carvolix | 140.47M |
| Diagnostic Medical Systems | 34.32M |
| Theraclion | 29.60M |
| Novacyt | 27.29M |
| Implanet | 25.62M |
| Ikonisys | 25.43M |